AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06700850 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Prototype dressing rectangle
Description: Prototype multilayer foam wound dressing with polyurethane, cellulose, superabsorbent polymer, silicone adhesive, acrylic adhesive. LDPE (Low Density Polyethylene). Size: 30x10cm. Topical application. Single use.
Study NCT06700850 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Marketed dressing rectangle
Description: CE marked multilayer foam wound dressing with silicone, polyurethane, viscose, polyester, polyolefins, polyacrylate and superabsorbent acrylate fibres. Size: 30x10cm. Topical application. Single use
Study NCT06700850 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Prototype dressing square
Description: Prototype multilayer foam wound dressing with polyurethane, cellulose, superabsorbent polymer, silicone adhesive, acrylic adhesive. LDPE (Low Density Polyethylene). Size: 7.5x7.5cm. Topical application. Single use.
Study NCT06700850 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Marketed dressing square
Description: CE marked multilayer foam wound dressing with silicone, polyurethane, viscose, polyester, polyolefins, polyacrylate and superabsorbent acrylate fibres. Size: 7.5x7.5cm. Topical application. Single use.
Study NCT06704022 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Oral nutritional supplement
Description: Consumption of the oral nutritional supplement
Study NCT06703047 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ATRA+pd-1+chemo
Description: All trans tretinoic acid+tislelizumab+chemotherapy (paclitaxel, cisplatin, or carboplatin)
Study NCT06703047 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: placebo+PD-1+chemo
Description: Placebo+tislelizumab+chemotherapy (paclitaxel, cisplatin, or carboplatin)
Study NCT05793060 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Dexmedetomidine Hydrochloride
Description: Dexmedetomidine 50 Mcg
Study NCT05793060 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Dexamethasone Phosphate
Description: Dexamethasone 4 mg
Study NCT05456321 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Active tDCS
Description: Active Transcranial Direct Current Stimulation (tDCS)
Study NCT05456321 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Cognitive Training
Description: Computerized Cognitive Training
Study NCT05456321 — intervention group
Intervention type: BEHAVIORAL
Group type: SHAM_COMPARATOR
Intervention: Cognitive Training
Description: Computerized Cognitive Training
Study NCT05456321 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham tDCS
Description: Sham Transcranial Direct Current Stimulation (tDCS)
Study NCT04479943 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: MOVIN
Description: MOVIN is a multi-component unit-based intervention comprised of five components that are implemented simultaneously in a hospital unit. The five components are: 1) psychomotor skills training, 2) unit ambulation culture, 3) communication, 4) resources, 5) ambulation environment.
Study NCT04479943 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Surveys and Focus groups
Description: Nurses will answer surveys about nurse behavior, changes in self-efficacy, frequency and distance of patient ambulation, documentation of ambulation, qualitative data collected to determine barriers to implementation
Study NCT05621239 — intervention group
Intervention type: BIOLOGICAL
Intervention: BNT162b2
Description: BNT162b2 half dose and full dose
Study NCT05297734 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Receive technology-based supportive cancer care
Description: All participants will receive an electronic health record message or email with standardized information provided regarding advance care planning and symptom management.
Study NCT05297734 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Receive redesigned team-based supportive cancer care
Description: Lay Health Workers will meet with 1:1 with participants over 12 months to discuss advance care planning, surrogate decision-makers, advance directives and physician orders for life sustaining treatment.
Study NCT06452316 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: CSB-001 Ophthalmic Solution 0.1%
Description: CSB-001: human recombinant dHGF (5-amino acid deleted hepatocyte growth factor)
Study NCT04760275 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Fluoxetine
Description: This will be a single-blind SMART design of 24 weeks duration that will employ two sequential levels of randomization, one in each of two 12-week stages of the study.~In Stage 1, participants will be randomized 1:1 to receive 12 weeks of the medication fluoxetine in upward-titrated dosages. In Stage 2, also 12 weeks in duration, participants who remit during the first 12 weeks of treatment will continue maintenance-level therapy with fluoxetine. All participants who do not remit will be randomized (1:1) to either (1) optimization of fluoxetine (increasing the dose of fluoxetine as tolerated), or (2) optimization of fluoxetine and addition of Cognitive Behavioral Therapy (CBT).
Study NCT04760275 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Cognitive Behavioral Therapy (CBT)
Description: This will be a single-blind SMART design of 24 weeks duration that will employ two sequential levels of randomization, one in each of two 12-week stages of the study.~In Stage 1, participants will be randomized 1:1 to receive 12 weeks of weekly CBT implemented with Coping Cat (CC). In Stage 2, also 12 weeks in duration, participants who remit during the first 12 weeks of treatment will continue maintenance-level therapy with CBT. All participants who do not remit will be randomized (1:1) to either (1) optimization of CBT (intensifying exposure practice and skills review), or (2) optimization of CBT and addition of the medication fluoxetine.
Study NCT06652035 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Intervention: Quevir® (Quercetin Phytosome®)
Description: 500 mg Quevir® (Quercetin Phytosome®) tablet
Study NCT06652035 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Intervention: Bactoblis®
Description: Probiotic Streptococcus Salivarius K12 (ATCC BAA-1024)
Study NCT06662708 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Accurate Prediction Artificial Intelligence Models
Description: Diagnostic Test: Accurate Prediction Artificial Intelligence Models Post-operative pathology, precise pre-operative diagnosis (including benign and malignant, invasive, grading, subtypes) or 3D lesion modelling will be predicted based on the AI predictive model in response to the information provided
Study NCT06664060 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: osteoimplant
Description: 30 lower third molars will be selected and prescribed preoperative treatment with two units of Osteoimplant Complex® 5 days prior to surgery and postoperative treatment with one unit of Osteoimplant® for 8 weeks from the time of surgery. Both nutritional supplements will be administered every 24 hours.
Study NCT06664060 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: 30 lower wisdom teeth will be selected and prescribed placebo, both preoperatively 5 days prior to surgery and postoperatively for 8 weeks from the time of surgery.
Study NCT06664632 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Exp
Description: Participants in this group will receive treatment using the Knee Sync Partner, a novel portable device designed to provide electrical traction and stimulation specifically for the knee joint.~controlled mechanical traction to the knee joint to reduce joint contact pressure, enhance synovial fluid flow, and increase joint space. This is expected to alleviate pain and improve mobility.
Study NCT06664632 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: control
Description: This will include a combination of isometric and isotonic exercises aimed at strengthening the knee musculature, enhancing joint stability, and reducing pain. The exercise regimen will focus on major muscle groups supporting the knee, such as the quadriceps, hamstrings, and calf muscles.
Study NCT06663228 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: MMS
Description: miniature mass spectrometry with AI assistance
Study NCT06662760 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TQB3002 Tablets
Description: TQB3002 is a fourth-generation small molecule Epidermal growth factor receptor (EGFR) inhibitor, which inhibits relevant tyrosine kinase activity and intracellular phosphorylation process by competitively binding to Adenosine triphosphate (ATP) site of intracellular tyrosine kinase binding domain, thereby inhibiting EGFR downstream signaling, ultimately achieving the purpose of inhibiting tumor growth.
Study NCT06664645 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: LHB tendon reinforcement
Description: complete repair with LHB tendon reinforcement
Study NCT06664645 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: complete repair without reinforcement
Description: conventional rotator cuff complete repair without reinforcement
Study NCT06662773 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TQB3616 capsule + itraconazole
Description: C2/4/6 inhibitors + CYP3A metabolic enzyme inhibitors
Study NCT06662773 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TQB3616 capsule + rifampicin
Description: C2/4/6 inhibitors + Non-specific cytochrome P450 enzyme inducer
Study NCT06664723 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: high tone external muscle stimulation
Description: Device HiToP®: Parameters of (HTEMS), Voltage: 230-V Pulse widths: ≤350 mA. Electrical Frequency: Frequencies continuously scanned from 4096 Hz to 31768 Hz, allowing for a much higher power of up to 5000 m W. Intensity: the electrical stimulation will be adjusted to a pleasant level that will not produce any pain or discomfortable paraesthesia, Duration 30 minutes per session. Electrodes will be placed around ulcer. It will be introduced 3 times per week, for 8 weeks Prior to intervention, skin sensation will be assessed using warm water in a test-tube (temperature), pin prick (pain) and cotton wool (light touch) to ascertain the skin sensitivity
Study NCT06664723 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Standard medical treatment (SMT)
Description: The Standard care of diabetic foot ulcers includes good glycemic control, adequate nutrition, off-loading (via bed rest or casts), local care (moist dressings and topical management), lessening of edema, surgical debridement of devitalized wound tissue and antibiotic therapy.
Study NCT06664723 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Standard medical treatment (SMT)
Description: The Standard care of diabetic foot ulcers includes good glycemic control, adequate nutrition, off-loading (via bed rest or casts), local care (moist dressings and topical management), lessening of edema, surgical debridement of devitalized wound tissue and antibiotic therapy.
Study NCT06662838 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Ergonomics Awareness and First Aid Training Program
Description: The ergonomic awareness and first aid training program includes training on possible situations that children of seasonal agricultural worker families may encounter in the field.
Study NCT06663215 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: School Based Bullying Prevention Program
Description: Three forms were administered to the adolescents: Personal Information Form, Bullying and Cyberbullying Scale for Adolescents (BCE-A) and Adolescent Future Expectations Scale. Adolescents were included in a school-based bullying prevention program the next day. One month later, the forms were administered again.
Study NCT05747118 — intervention group
Intervention type: BEHAVIORAL
Intervention: Physical training
Description: A 12 week supervised training intervention with 1 hour physical training two times a week.
Study NCT04286594 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CBD
Description: Participants will receive CBD solution during the open-label phase of the trial.
Study NCT06664125 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: JMKX003002 will be administered orally
Description: tablets for oral administration.
Study NCT06664125 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Sevelamer carbonate
Description: tablets for oral administration.
Study NCT06663657 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Cognitive Sensorimotor Exercises
Description: Patients in group A will receive cognitive sensorimotor exercises for 30 minutes, sessions for 5 days per week for 8 weeks.
Study NCT06663657 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Task Oriented Training group
Description: Patients in group B will receive task oriented training for 30 minutes, sessions for 5 days per week for 8 weeks.
Study NCT06662955 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: audible cues
Description: Terminal knee extension exercise with audible cues
Study NCT06662955 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Exercise
Description: Terminal knee extension exercise
Study NCT06662877 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Albumin-bound Paclitaxel + Tegafur Gimeracil Oteracil (S-1) + Anlotinib
Description: Albumin-bound Paclitaxel, 125mg/m2,iv.drip,d1,d8,Q3W +Tegafur Gimeracil Oteracil (S-1) 40-60mg,p.o,bid,d1-d14,Q3W+Anlotinib 10mg,p.o,d1-d14,Q3W
Study NCT06662877 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Oxaliplatin + Leucovorin + Fluorouracil (FOLFOX regimen)
Description: Oxaliplatin 85 mg/m2,d1,iv.drip,Q2W + Leucovorin 400mg/m2,d1,iv.drip,Q2W+ Fluorouracil 2400 mg/m2 civ46h, Q2W
Study NCT06156215 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Vaccine Messaging
Description: 1. Video clips - short (approximately 3-minute) Public Service Announcement type videos to be viewed by participant using a QR code on their smartphone. If no smartphone is available, the video will be shown to the participant on an iPad.~2. Printed materials - one page information sheets handed to subjects by CRCs.~3. Face to face messaging - short (\< 1 minute), scripted message from the patient's providers in the ED (nurse or provider)~Each site will maintain a library of~A. 5 versions of the videos - the version used in any participant will be tailored to that participant's stated race/ethnicity.~B. 5 versions of printed flyers - likewise, the version will be tailored to the participant's stated race/ethnicity.~C. 1 version of scripted message to be delivered in English or Spanish.
Study NCT06156215 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Vaccine Acceptance Question
Description: The last question in the Vaccine Acceptance Survey in both the Intervention M and Intervention Q arms of the study is Would you accept the COVID-19 booster vaccine in the emergency department today if your doctor asked you?
Study NCT06156215 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Vaccine Acceptance Question
Description: The last question in the Vaccine Acceptance Survey in both the Intervention M and Intervention Q arms of the study is Would you accept the COVID-19 booster vaccine in the emergency department today if your doctor asked you?
Study NCT04763772 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Body Fat Distribution Imaging Report
Description: Those randomized to body fat distribution imaging will be scanned on a 1.5 Tesla Siemens Aera MRI scanner (Siemens, Erlangen, Germany), located in the Center for Advanced Heart and Vascular Care using a 6-minute dual-echo Dixon Vibe protocol providing a water and fat separated volumetric data set covering neck to knees, and a multiecho Dixon acquisition for proton density fat fraction assessment in the liver. Images of the liver will be acquired using a 16-channel SENSE extra large Torso coil and images from the rest of the body will be acquired using the body coil. Volumetric imaging datasets of the body derived by MRI will be generated and adipose tissue/fat depots will be quantified: abdominal subcutaneous compartment (ASAT), visceral compartment (VAT), and hips and buttocks (lower body fat); proton density fat fraction of the liver (i.e. hepatic steatosis) as well as the quality of lean (skeletal muscle) including muscle volume and degree of fat infiltration.
Study NCT04763772 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: PLACEBO_COMPARATOR
Intervention: Basic Weight Information
Description: Body weight and body mass index
Study NCT04763772 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Patient Provided
Description: Body weight/fat distribution information will be provided directly to the patient
Study NCT04763772 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Physician Provided
Description: Body weight/fat distribution information will be provided directly to the physician
Study NCT04754581 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Maximal ATP Production (ATPmax)
Description: ATPmax will be measured in order to determine in vivo mitochondrial capacity. The magnetic resonance scans to measure mitochondrial energetics will also be performed.
Study NCT04754581 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Exercise Testing (VO2max)
Description: Aerobic fitness level will be assessed while participant pedals on a stationary bicycle/walk on a treadmill. The volume of oxygen intake and carbon dioxide (CO2) production will be measured.
Study NCT04754581 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Muscle Biopsy
Description: Sample muscle cells from the left leg Vastus Lateralis (thigh) muscle.
Study NCT04754581 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Adipose Tissue Biopsy
Description: Sample fat tissue from the abdomen.
Study NCT04754581 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Hyperinsulinemic euglycemic clamp
Description: Measurement of insulin sensitivity.
Study NCT04754581 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: PET imaging
Description: After an overnight fast, an intravenous catheter will be placed in each arm (one with arterial line for PET infusion, and the other for infusion of insulin, glucose, and 6,6 D2 glucose tracer. FDG-glucose will be injected followed by 90-minute PET scanning of the thigh.
Study NCT06311994 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Virtual reality
Description: Factors that may affect patient compliance with the VR-based intervention method to be applied to patients undergoing knee surgery and the factors that may affect the measurements to be performed were evaluated through a literature review and inclusion and exclusion criteria were created.
Study NCT06632028 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: artificial intelligence assisted spinal rehabilitation
Description: In artificial intelligence-based rehabilitation, it is more advantageous compared to other treatment methods in terms of the fact that technology applications can be designed according to the level and abilities of the individual and that the parameters such as duration, intensity, difficulty and speed of the treatment can be flexibly configured for the therapist and the patient.
Study NCT06632028 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: artificial intelligence assisted spinal rehabilitation
Description: In artificial intelligence-based rehabilitation, it is more advantageous compared to other treatment methods in terms of the fact that technology applications can be designed according to the level and abilities of the individual and that the parameters such as duration, intensity, difficulty and speed of the treatment can be flexibly configured for the therapist and the patient.
Study NCT06632028 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: conventional therapy
Description: In cervical disc herniation, non-invasive physical therapy applications such as laser treatment, hot-cold treatment methods, Transcutaneous Electrical Nerve Stimulation (TENS), interferential currents, manual therapy applications, kinesiological taping and exercise therapy, as well as painkillers and nonsteroidal anti-inflammatory drugs and antidepressive drugs are among the most preferred methods in treatment.(6)
Study NCT06632028 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: conventional therapy
Description: In cervical disc herniation, non-invasive physical therapy applications such as laser treatment, hot-cold treatment methods, Transcutaneous Electrical Nerve Stimulation (TENS), interferential currents, manual therapy applications, kinesiological taping and exercise therapy, as well as painkillers and nonsteroidal anti-inflammatory drugs and antidepressive drugs are among the most preferred methods in treatment.(6)
Study NCT05932290 — intervention group
Intervention type: DRUG
Intervention: Elranatamab
Description: BCMA-CD3 bispecific antibody
Study NCT05932290 — intervention group
Intervention type: DRUG
Intervention: Standard of care
Description: Standard of care
Study NCT05694559 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Genetic Testing and Counseling
Description: Participants will complete testing
Study NCT05694559 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Screening Form
Description: Participants will complete forms with demographics and history
Study NCT05854290 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: CRT
Description: Participants will complete an 8-week intervention, 2 sessions per week. Co-INTEGRATE sessions take 30-50 minutes to complete. Weekly on the day of the last therapy session, before or after the session, all patients, regardless of the group assigned to, will be asked to complete an electronic brief questionnaire to provide information, on sleep, recreational habits, alcohol intake, exercise, and smoking.